Lv1
90 积分 2024-12-11 加入
Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes
12小时前
已完结
Chiglitazar: First Approval
12小时前
已完结
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
12小时前
待确认
PCSK9 MONOCLONAL ANTIBODY RECATICIMAB IN ADULT HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (REMAIN-3): A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY
1个月前
已完结
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia
1个月前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia
1个月前
已完结
Effects of sodium‐glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes mellitus: A systematic review and network meta‐analysis
1个月前
已完结
Incident hyperuricemia in relation to antihypertensive therapy with the irbesartan/hydrochlorothiazide combination
2个月前
已完结
A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c ≥9–15%: DUAL HIGH Trial
2个月前
已完结
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials
2个月前
已完结
皖公网安备34019202002308
